Transdermal progesterone cream as an alternative progestin in hormone therapy

Alternative Therapies in Health and Medicine

Volumn 11, Issue 6, 2005, Pages 36-38

  Leonetti, Helene B ^a   Landes, Jennifer ^a   Steinberg, David ^a   Anasti, James N ^a  

^a ST LUKE S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; PROGESTERONE; ESTROGEN; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DRUG EFFECT; DRUG PREFERENCE; ENDOMETRIAL DISEASE; ENDOMETRIUM ATROPHY; ENDOMETRIUM BIOPSY; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM PROLIFERATION; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MENOPAUSE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; VAGINA BLEEDING; AGED; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG COMBINATION; ENDOMETRIUM; ESTROGEN THERAPY; INTRADERMAL DRUG ADMINISTRATION; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATIENT SATISFACTION; STATISTICS; TIME; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; AGED; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ENDOMETRIUM; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; PATIENT SATISFACTION; PROGESTERONE; TIME FACTORS; TREATMENT OUTCOME;

EID: 33644832795     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Postmenopausal hormone replacement therapy: scientific review. JAMA. 2002; 288:872-881.
2. Lethaby A, Farquhar C, Sarkis A, et al. Hormone replacement therapy in post-menopausal women: endometrial hyperplasia and irregular bleeding. Cochrane Database Syst Rev. 2000;(2):CD000402.
3. Panay N, Studd J. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Hum Reprod Update. 1997;3:159-171.
4. Leonetti HB, Longo S, Anasti JN. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol. 1999;94:225-228.
5. Leonetti HB, Wilson KJ, Anasti JN. Topical progesterone cream has an antiproliferative effect on estrogen-stimulated endometrium. Fertil Steril. 2003;79:221-222.
6. Wren BG, Champion SM, Willetts K, Manga RZ, Eden JA. Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women. Menopause. 2003;10:13-18.
7. Cooper A, Spencer C, Whitehead MI, et al. Systemic absorption of progesterone from Progest cream in postmenopausal women. Lancet. 1998;351:1255-1256.
8. Wren BG, McFarland K, Edwards L, et al. Effect of sequential transdermal progesterone cream on endometrium, bleeding pattern, and plasma progesterone and salivary progesterone levels in postmenopausal women. Climacteric. 2000;3:155-160.
9. Affinito P, Di Carlo C, Di Mauro P, Napolitano V, Nappi C. Endometrial hyperplasia: efficacy of a new treatment with a vaginal cream containing natural micronized progesterone. Maturitas. 1994;20:191-198.
10. Simon JA. Micronized progesterone: vaginal and oral uses. Clin Obstet Gynecol. 1995;38:902-914.
11. Burry KA, Patton PE, Hermsmeyer K. Percutaneous absorption of progesterone in postmenopausal women treated with transdermal estrogen. Am J Obstet Gynecol. 1999;180:1504-1511.
12. O'Leary P, Feddema P, Chan K, Taranto M, Smith M, Evans S. Salivary, but not serum or urinary levels of progesterone are elevated after topical application of progesterone cream to pre-and postmenopausal women. Clin Endocrinol. 2000;53:615-620.
13. Lewis JG, McGill H, Patton VM, Elder PA. Caution on the use of saliva measurements to monitor absorption of progesterone from transdermal creams in postmenopausal women. Maturitas. 2002;41:1-6.
14. Levine H, Watson N. Comparison of the pharmacokinetics of crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women(3). Fertil Steril. 2000;73:516-521.
15. Woodruff JD, Pickar JH. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group. Am J Obstet Gynecol. 1994;170:1213-1223.
16. Mircioiu C, Perju A, Griu E, et al. Pharmacokinetics of progesterone in post-menopausal women: 2. Pharmacokinetics following percutaneous administration. Eur J Drug Metab Pharmacokinet. 1998;23:397-402.